Basic Research
Copyright ©2005 Baishideng Publishing Group Inc.
World J Gastroenterol. Nov 28, 2005; 11(44): 6960-6967
Published online Nov 28, 2005. doi: 10.3748/wjg.v11.i44.6960
Figure 2
Figure 2 Hepatic NF-κB activation (A) and NF-κB DNA binding activities presented as IOD value (B). Lanes 1 and 2: Hepatic RNA extracts from sham control group. Lanes 3 and 4: Hepatic RNA extracts from I/R group. Lanes 5 and 6: Hepatic RNA extracts from I/R + NF-κB decoy ODNs group. b, dP<0.001 vs sham group, f, hP<0.001 vs I/R group.